Residual risk for transfusion-transmitted HIV and cost-benefit for HIV nucleic acid amplification technology (NAT) in Brazil.

被引：0
|
作者：
Amorim, L
Silvia, C
Dias, S
Lobo, C
Motta, K
MacDowell, B
机构：
[1] Hemorio, Rio De Janeiro, Brazil
[2] Anvisa, Brasilia, DF, Brazil
来源：
TRANSFUSION | 2002年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3S / 3S
页数：1
相关论文
共 50 条
  • [1] Estimated risk of transfusion-transmitted HIV infection in Sao Paulo, Brazil
    Sabino, EC
    Salles, N
    Sáez-Alquézar, A
    Ribeiro-dos-Santos, G
    Chamone, DF
    Busch, MP
    TRANSFUSION, 1999, 39 (10) : 1152 - 1153
  • [2] The Residual Risk of Transfusion-Transmitted HIV Infections in Taiwan Between 2000 and 2007
    Yang, T.
    Huang, L.
    Twu, L.
    Yang, P.
    Kuo-Sin, L.
    TRANSFUSION, 2009, 49 : 214A - 214A
  • [3] Estimated risk of HIV and HCV transfusion-transmitted in Italy
    Gonzalez, MA
    Régine, V
    Piccinini, V
    Vulcano, F
    Giampaolo, A
    Hassan, HJ
    TRANSFUSION, 2004, 44 (09) : 88A - 89A
  • [4] The residual risk of transfusion-transmitted HIV infection in a public Brazilian blood center.
    Pinto, Ana Cristina S.
    Valente, Vanderleia B.
    Ubiali, Eugenia Maria A.
    Angulo, Ivan L.
    Covas, Dimas T.
    BLOOD, 2006, 108 (11) : 115B - 115B
  • [5] Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of Nucleic Acid Testing
    Pillonel, J
    Laperche, S
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2004, 11 (02) : 81 - 86
  • [6] Residual risk estimation of transfusion-transmitted HIV, HBV, HCV, HTLV and chagas disease at Sao Paulo-Brazil
    Araujo, P.
    Carvalho, F.
    Barreto, J. A.
    TRANSFUSION, 2008, 48 (02) : 107A - 107A
  • [7] Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases
    McCullough, J
    Bianco, C
    Bracey, A
    Busch, M
    Dodd, RY
    Gammon, RR
    Harrison, C
    Jackson, JB
    Katz, LM
    Kleinman, S
    McFarland, J
    Page, P
    Preston, S
    Sher, GD
    Sherman, L
    Simon, T
    Stramer, SL
    Stroncek, D
    Young, CT
    Hewlett, IK
    TRANSFUSION, 2000, 40 (02) : 143 - 159
  • [8] Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy
    Velati, C
    Romanò, L
    Baruffi, L
    Pappalettera, M
    Carreri, V
    Zanetti, AR
    TRANSFUSION, 2002, 42 (08) : 989 - 993
  • [9] Prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections; JRC NAT Screening Research
    Tamori, Akihiro
    Tani, Yoshihiko
    Aso, Hideki
    Malsukura, Harumichi
    Fujino, Keizo
    Kawada, Norifumi
    Nishiguchi, Shuhei
    HEPATOLOGY, 2012, 56 : 629A - 630A
  • [10] Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil
    de Miranda Correa, Angelita Silva
    Lamarao, Leticia Martins
    Moura Vieira, Priscilla Cristina
    Hermes de Castro, Renata Bezerra
    Costa de Almeida, Nubia Caroline
    Americo de Castro, Jairo Augusto
    Maciel de Lima, Maria Salete
    Palmeira, Mauricio Koury
    Langanke Pedroso Meireles, Ana Luiza
    Burbano, Rommel Rodriguez
    PLOS ONE, 2018, 13 (12):
12345